Advanced

Von Willebrand disease.

Berntorp, Erik LU (2012) In Pediatric Blood & Cancer
Abstract
Long-term prophylaxis is not as well known in Von Willebrand disease (VWD) as in hemophilia but attempts to evaluate prophylaxis scientifically in VWD have started. A few cohort studies have been reported. In an international effort the Von Willebrand disease prophylaxis network (VWD PN) has been formed to investigate the role of prophylaxis in clinically severe VWD (e.g., patients with type 3 VWD) that is nonresponsive to other treatments. Findings from the VWD PN studies will hopefully provide more robust evidence for which patients might best benefit from prophylaxis and for appropriate dosing regimens for prophylaxis in patients with VWD. Pediatr Blood Cancer © 2012 Wiley Periodicals, Inc.
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Pediatric Blood & Cancer
publisher
John Wiley and Sons Inc.
external identifiers
  • wos:000311166600010
  • pmid:23109385
  • scopus:84869233625
ISSN
1545-5017
DOI
10.1002/pbc.24337
language
English
LU publication?
yes
id
64c46dd2-37ba-40bb-9d7d-066b9b429f70 (old id 3160277)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/23109385?dopt=Abstract
date added to LUP
2012-11-01 12:00:20
date last changed
2017-01-01 07:38:21
@article{64c46dd2-37ba-40bb-9d7d-066b9b429f70,
  abstract     = {Long-term prophylaxis is not as well known in Von Willebrand disease (VWD) as in hemophilia but attempts to evaluate prophylaxis scientifically in VWD have started. A few cohort studies have been reported. In an international effort the Von Willebrand disease prophylaxis network (VWD PN) has been formed to investigate the role of prophylaxis in clinically severe VWD (e.g., patients with type 3 VWD) that is nonresponsive to other treatments. Findings from the VWD PN studies will hopefully provide more robust evidence for which patients might best benefit from prophylaxis and for appropriate dosing regimens for prophylaxis in patients with VWD. Pediatr Blood Cancer © 2012 Wiley Periodicals, Inc.},
  author       = {Berntorp, Erik},
  issn         = {1545-5017},
  language     = {eng},
  publisher    = {John Wiley and Sons Inc.},
  series       = {Pediatric Blood & Cancer},
  title        = {Von Willebrand disease.},
  url          = {http://dx.doi.org/10.1002/pbc.24337},
  year         = {2012},
}